• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD11c+CD5+慢性B细胞白血病的特征以及具有慢性淋巴细胞白血病免疫表型的新型外周血B细胞亚群的鉴定。

Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes.

作者信息

Wormsley S B, Baird S M, Gadol N, Rai K R, Sobol R E

机构信息

Cytometrics, Inc., San Diego, CA 92121.

出版信息

Blood. 1990 Jul 1;76(1):123-30.

PMID:1694698
Abstract

Previous studies have indicated that chronic lymphocytic leukemias (CLL) are characterized by the coexpression of CD5 and B-cell antigens, while hairy cell leukemias (HCL) typically express CD11c+CD5- B-cell immunophenotypes. In this report we describe the features of B-cell leukemias with CD11c+CD5+ immunophenotypes and the identification of novel circulating B-cell subsets defined by the expression of CD20, CD5, and CD11c antigens. Morphologic evaluation of 14CD11c+CD5+ B-cell leukemias showed that they generally had larger cellular diameters (14 to 21 microns) and lower nuclear:cytoplasm ratios than typical small lymphocyte CLL. These cases did not exhibit the well-defined nucleoli characteristic of prolymphocytic leukemia (PLL). The presenting clinical features of CD11c+CD5+ B-cell leukemias were most consistent with CLL or PLL, and none of the evaluated cases had pancytopenia, splenomegaly, and cytoplasmic villi characteristic of HCL. Examination of normal peripheral blood (n = 6) by three-color flow cytometry identified four novel B-cell subsets with the following immunophenotypes (mean percent of total CD20+ B cells +/- SE): CD20+CD5+CD11c+ (8.0 +/- 1.6); CD20+CD5-CD11c+ (12.0 +/- 2.0); CD20+CD5+CD11c- (35.0 +/- 4.9); and CD20+CD5-CD11c- (44.0 +/- 5.0). Our findings suggest that CD11c+CD5+ B-cell leukemias with atypical morphologic features represent forms of CLL or PLL rather than HCL. In addition, we have identified novel subsets of circulating B cells defined by patterns of CD20, CD5, and CD11c expression that correspond to the immunophenotypes of chronic B-cell leukemias.

摘要

以往研究表明,慢性淋巴细胞白血病(CLL)的特征是CD5和B细胞抗原共表达,而毛细胞白血病(HCL)通常表达CD11c+CD5- B细胞免疫表型。在本报告中,我们描述了具有CD11c+CD5+免疫表型的B细胞白血病的特征,并鉴定了由CD20、CD5和CD11c抗原表达所定义的新型循环B细胞亚群。对14例CD11c+CD5+ B细胞白血病进行形态学评估显示,与典型小淋巴细胞CLL相比,它们通常具有更大的细胞直径(14至21微米)和更低的核质比。这些病例未表现出幼淋巴细胞白血病(PLL)特征性的清晰核仁。CD11c+CD5+ B细胞白血病的主要临床特征与CLL或PLL最为一致,且所有评估病例均无HCL特征性的全血细胞减少、脾肿大和细胞质绒毛。通过三色流式细胞术检测正常外周血(n = 6),鉴定出四个新型B细胞亚群,其免疫表型如下(占总CD20+B细胞的平均百分比±标准误):CD20+CD5+CD11c+(8.0±1.6);CD20+CD5-CD11c+(12.0±2.0);CD20+CD5+CD11c-(35.0±4.9);以及CD20+CD5-CD11c-(44.0±5.0)。我们的研究结果表明,具有非典型形态特征的CD11c+CD5+ B细胞白血病代表CLL或PLL的形式,而非HCL。此外,我们已经鉴定出由CD20、CD5和CD11c表达模式所定义的新型循环B细胞亚群,它们与慢性B细胞白血病的免疫表型相对应。

相似文献

1
Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes.CD11c+CD5+慢性B细胞白血病的特征以及具有慢性淋巴细胞白血病免疫表型的新型外周血B细胞亚群的鉴定。
Blood. 1990 Jul 1;76(1):123-30.
2
CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.CD11c(LEU-M5)表达特征为一种兼具慢性淋巴细胞白血病和毛细胞白血病特征的B细胞慢性淋巴细胞增殖性疾病。
Blood. 1990 Dec 1;76(11):2360-7.
3
Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases.B 慢性(成熟)淋巴细胞白血病亚型的免疫表型分析。242 例研究。
Cancer. 1992 Nov 15;70(10):2436-43. doi: 10.1002/1097-0142(19921115)70:10<2436::aid-cncr2820701009>3.0.co;2-c.
4
Surface phenotype and adhesion activity of B-cell chronic lymphoid leukemias.
Leuk Lymphoma. 1993 Jun;10(3):209-16. doi: 10.3109/10428199309145885.
5
CD5+ chronic B-cell leukemia with features intermediate to chronic lymphocytic leukemia and hairy cell leukemia.具有介于慢性淋巴细胞白血病和毛细胞白血病之间特征的CD5阳性慢性B细胞白血病。
Hematol Pathol. 1994;8(3):99-109.
6
[The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].[260例CD5 + B细胞淋巴增殖性疾病患者的免疫表型特征]
Zhonghua Xue Ye Xue Za Zhi. 2014 Apr;35(4):337-41. doi: 10.3760/cma.j.issn.0253-2727.2014.04.019.
7
Clinical utility of flow cytometry in the chronic lymphoid leukemias.流式细胞术在慢性淋巴细胞白血病中的临床应用
Semin Oncol. 1998 Feb;25(1):6-10.
8
The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.B细胞疾病的免疫特征及慢性淋巴细胞白血病诊断评分系统的提议。
Leukemia. 1994 Oct;8(10):1640-5.
9
Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.CD20抗原表达降低作为慢性淋巴细胞白血病的特征性标志物。
Am J Hematol. 1992 Aug;40(4):259-63. doi: 10.1002/ajh.2830400404.
10
CD20 and CD5 expression in B-chronic lymphocytic leukemia.B 细胞慢性淋巴细胞白血病中 CD20 和 CD5 的表达
Ann N Y Acad Sci. 1992 May 4;651:480-3. doi: 10.1111/j.1749-6632.1992.tb24651.x.

引用本文的文献

1
BCR activated CLL B cells use both CR3 (CD11b/CD18) and CR4 (CD11c/CD18) for adhesion while CR4 has a dominant role in migration towards SDF-1.BCR 激活的 CLL B 细胞在黏附时既利用 CR3(CD11b/CD18)又利用 CR4(CD11c/CD18),而 CR4 在向 SDF-1 迁移中起主要作用。
PLoS One. 2021 Jul 20;16(7):e0254853. doi: 10.1371/journal.pone.0254853. eCollection 2021.
2
Activated Human Memory B Lymphocytes Use CR4 (CD11c/CD18) for Adhesion, Migration, and Proliferation.活化的人记忆 B 淋巴细胞利用 CR4(CD11c/CD18)进行黏附、迁移和增殖。
Front Immunol. 2020 Sep 29;11:565458. doi: 10.3389/fimmu.2020.565458. eCollection 2020.
3
Is Cd11c and Fmc7 Negativity in Chronic Lymphocytic Leukemia Poor Prognostic?
慢性淋巴细胞白血病中CD11c和FMC7阴性是否预后不良?
Indian J Hematol Blood Transfus. 2020 Jan;36(1):84-90. doi: 10.1007/s12288-019-01169-8. Epub 2019 Aug 13.
4
Regulated expression and function of CD11c/CD18 integrin on human B lymphocytes. Relation between attachment to fibrinogen and triggering of proliferation through CD11c/CD18.人B淋巴细胞上CD11c/CD18整合素的调控表达与功能。通过CD11c/CD18与纤维蛋白原结合和触发增殖之间的关系。
J Exp Med. 1991 Dec 1;174(6):1313-22. doi: 10.1084/jem.174.6.1313.